Collagens in primary frozen shoulder: expression of collagen mRNA isoforms in the different phases of the disease.
Adult
Biopsy
Bursitis
/ genetics
Case-Control Studies
Collagen
/ genetics
Collagen Type I
/ genetics
Collagen Type III
/ genetics
Collagen Type IV
/ genetics
Collagen Type V
/ genetics
Collagen Type VI
/ genetics
Disease Progression
Female
Gene Expression
Humans
Joint Capsule
/ metabolism
Ligaments
/ metabolism
Male
Matrix Metalloproteinase 14
/ genetics
Matrix Metalloproteinase 2
/ genetics
Middle Aged
RNA, Messenger
/ metabolism
Transforming Growth Factor beta1
/ genetics
Transforming Growth Factor beta2
/ genetics
Transforming Growth Factor beta3
/ genetics
Up-Regulation
collagen turnover
disease activity
fibroblasts
frozen shoulder
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
02 08 2021
02 08 2021
Historique:
received:
23
03
2020
revised:
24
09
2020
pubmed:
22
12
2020
medline:
24
8
2021
entrez:
21
12
2020
Statut:
ppublish
Résumé
Primary frozen shoulder (pFS) has three phases that differ in clinical presentation. It is characterized by contracture of the joint capsule. We hypothesized that there is a general upregulation of collagens in pFS, and that this is highest in the first phase of the disease. The aims of this study were to investigate the expression of various collagens and degradation of collagens in patients with primary pFS and relate this to the three phases of the condition. From twenty-six patients with pFS and eight control patients with subacromial impingement, biopsies were obtained during shoulder arthroscopy from the middle glenohumeral ligament and the anterior capsule, and mRNA levels for collagens, MMP-2 and -14 and TGF-β1, - β2 and -β3 in the tissue were analysed using real-time PCR. Genes for collagens type I, III, IV, V, VI and XIV, were activated in pFS, and the total mRNA for all collagens was increased (P < 0.05). This upregulation was independent of disease phases in pFS. In addition, MMP-2, MMP-14, TGF-β1 and TGF-β3 were upregulated in all phases of the disease. There is a general upregulation and an increased degradation of collagens in pFS in all three phases of the disease. This indicates a constantly increased turnover of the fibrotic tissue in the capsule from pFS. The difference in clinical presentation of pFS observed in the three phases of the disease is not primarily a result of variations in collagen production.
Identifiants
pubmed: 33347577
pii: 6043114
doi: 10.1093/rheumatology/keaa802
doi:
Substances chimiques
Collagen Type I
0
Collagen Type III
0
Collagen Type IV
0
Collagen Type V
0
Collagen Type VI
0
RNA, Messenger
0
TGFB1 protein, human
0
TGFB2 protein, human
0
TGFB3 protein, human
0
Transforming Growth Factor beta1
0
Transforming Growth Factor beta2
0
Transforming Growth Factor beta3
0
Collagen
9007-34-5
MMP2 protein, human
EC 3.4.24.24
Matrix Metalloproteinase 2
EC 3.4.24.24
MMP14 protein, human
EC 3.4.24.80
Matrix Metalloproteinase 14
EC 3.4.24.80
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3879-3887Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.